Form 8-K Entero Therapeutics, For: Sep 09
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Entero Therapeutics names new interim CEO after leadership change
September 9, 2025 5:05 PM EDTEntero Therapeutics Inc. (NASDAQ: ENTO) terminated Richard Joel Paolone as interim chief executive officer and chairman of the board without cause on September 3, 2025, according to a company statement.
The company said Paolone's termination was not due to any disagreement regarding financial reporting,... More
